{"id":"25368401","title":"Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024","author":null,"feed":"PRTGAM","feedName":"Newswire.ca","published":"Tue Apr 9, 2024","image":"N/A","content":"

Preliminary data demonstrate FPI-2265 is active in heavily pretreated patients with progressive metastatic castration-resistant prostate cancer (mCRPC), including those who received prior lutetium-based radioconjugates

","related":[{"id":"1549387","title":"SAKURA Internet Posts Higher Sales but Swings to Loss, Targets Earnings Rebound in FY2027","slug":"sakura-internet-posts-higher-sales-but-swings-to-loss-targets-earnings-rebound-in-fy2027","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549385","title":"SAKURA internet Beats FY2026 Forecast on GPU Infrastructure Demand and Cost Controls","slug":"sakura-internet-beats-fy2026-forecast-on-gpu-infrastructure-demand-and-cost-controls","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549383","title":"Lake Resources applies to quote additional fully paid ordinary shares on ASX","slug":"lake-resources-applies-to-quote-additional-fully-paid-ordinary-shares-on-asx","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549381","title":"TZ Limited Discloses Final Director Interest as Schiavello Steps Down","slug":"tz-limited-discloses-final-director-interest-as-schiavello-steps-down","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549379","title":"TZ Limited appoints new director with no initial security holdings","slug":"tz-limited-appoints-new-director-with-no-initial-security-holdings","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549377","title":"Impro Precision Lifts 2026 Sales Forecast After Strong First-Quarter Revenue Gain","slug":"impro-precision-lifts-2026-sales-forecast-after-strong-first-quarter-revenue-gain","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549375","title":"SSY Group Wins Chinese Approvals for Two Cardiovascular Injectables","slug":"ssy-group-wins-chinese-approvals-for-two-cardiovascular-injectables","feedName":"Tipranks","published":"8 minutes ago","categories":[]},{"id":"1549265","title":"Cenvios Triggers Compulsory Acquisition to Fully Take Over Sen Yue Holdings and Delist It from SGX Catalist","slug":"cenvios-triggers-compulsory-acquisition-to-fully-take-over-sen-yue-holdings-and-delist-it-from-sgx-catalist","feedName":"Tipranks","published":"24 minutes ago","categories":[]},{"id":"1549263","title":"TZ Limited refreshes board and hires advisers to bolster strategic and capital plans","slug":"tz-limited-refreshes-board-and-hires-advisers-to-bolster-strategic-and-capital-plans","feedName":"Tipranks","published":"24 minutes ago","categories":[]}],"sourceId":"newswireca-2024-4-9-fusion-pharmaceuticals-announces-presentation-of-interim-data-from-the-phase-2-tatcist-clinical-trial-evaluating-fpi-2265-at-the-aacr-annual-meeting-2024","media":"text","thumbnail":"N/A","canonicalUrl":"https://www.newswire.ca/news-releases/fusion-pharmaceuticals-announces-presentation-of-interim-data-from-the-phase-2-tatcist-clinical-trial-evaluating-fpi-2265-at-the-aacr-annual-meeting-2024-830482613.html","feedUrl":null,"slug":"fusion-pharmaceuticals-announces-presentation-of-interim-data-from-the-phase-2-tatcist-clinical-trial-evaluating-fpi-2265-at-the-aacr-annual-meeting-2024"}

Latest in

More

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024